- Home
- RNXT vs BGI Comparison
RNXT vs BGI Comparison
Compare RNXT & BGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNXT
- BGI
- Stock Information
- Founded
- RNXT 2012
- BGI 1879
- Country
- RNXT United States
- BGI Canada
- Employees
- RNXT N/A
- BGI N/A
- Industry
- RNXT Biotechnology: Pharmaceutical Preparations
- BGI
- Sector
- RNXT Health Care
- BGI
- Exchange
- RNXT Nasdaq
- BGI Nasdaq
- Market Cap
- RNXT 44.6M
- BGI 17.8M
- IPO Year
- RNXT 2021
- BGI 2005
- Fundamental
- Price
- RNXT $1.36
- BGI $1.00
- Analyst Decision
- RNXT Strong Buy
- BGI
- Analyst Count
- RNXT 2
- BGI 0
- Target Price
- RNXT $7.25
- BGI N/A
- AVG Volume (30 Days)
- RNXT 147.2K
- BGI 86.0K
- Earning Date
- RNXT 08-12-2025
- BGI 07-15-2025
- Dividend Yield
- RNXT N/A
- BGI N/A
- EPS Growth
- RNXT N/A
- BGI N/A
- EPS
- RNXT N/A
- BGI N/A
- Revenue
- RNXT $240,000.00
- BGI $131,596,265.00
- Revenue This Year
- RNXT $3,186.05
- BGI N/A
- Revenue Next Year
- RNXT $291.93
- BGI N/A
- P/E Ratio
- RNXT N/A
- BGI N/A
- Revenue Growth
- RNXT N/A
- BGI 4.01
- 52 Week Low
- RNXT $0.75
- BGI $0.76
- 52 Week High
- RNXT $1.69
- BGI $2.95
- Technical
- Relative Strength Index (RSI)
- RNXT 55.76
- BGI 61.49
- Support Level
- RNXT $1.27
- BGI $0.85
- Resistance Level
- RNXT $1.42
- BGI $0.99
- Average True Range (ATR)
- RNXT 0.07
- BGI 0.06
- MACD
- RNXT -0.02
- BGI 0.01
- Stochastic Oscillator
- RNXT 62.50
- BGI 92.86
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
About BGI Birks Group Inc.
Birks Group Inc is a part of the leisure industry. The company designs, develops, produces, and retails fine jewelry, timepieces, and gifts. Its operating segments include Retail and Other. The company generates maximum revenue from the Retail segment. Its retail segment consists of retail operations whereby it operates stores in Canada under the Maison Birks, Brinkhaus, Graff, and Patek Phillippe brands. The other segment consists mainly of wholesale business, e-commerce business, and gold exchange business.